Mesothelioma Prognosis
Your prognosis with mesothelioma depends mostly on the
stage and type of cancer you have. Improving that prognosis can depend
on finding a specialist with experience treating your form of the
disease.
Typical Prognosis
Improving your prognosis starts with having the right information
Get Your Free Guide Now
Cancer specialists diagnose between 2,000 and 3,000 new cases of mesothelioma
a year in the United States. When they confirm the existence of
asbestos cancer, they quickly turn to prognosis — their best estimate of
your battle ahead and also the probable outcome. Mesothelioma is a
difficult disease to beat. And while there are many aspects to it that
you can't control, there are things that you can do to help improve your
quality of life and possibly improve your survival.
Although prognosis varies greatly depending on the factors described
above, younger patients appear to have the most optimistic prognosis. A
2,959-patient study conducted by the American Cancer Society (ACS) noted
that nearly 37 percent of mesothelioma patients younger than 45 years
old survived for more than five years after diagnosis.
Approximately 20 percent of patients aged 45 to 54 survived for longer than five years.
According to a study published by the Journal of Thoracic Oncology, the survival rate for patients is generally considered to be one year.
Patients Surviving 3 or More Years Following a Mesothelioma Diagnosis (%)
Although the typical survival rate for
patients is low, there have been long-term survivors of the disease.
Read their survival stories on our Wall of Hope.
Factors That Affect Your Prognosis
Dr. Fontaine explains what treatments give patients the best chance to live longer
Your mesothelioma prognosis depends on several factors, including the
cancer's stage, plus your age, gender, overall health and history of
asbestos exposure. Unique qualities of your cancer at the time of
diagnosis such as the exact type of cancer you have, the cellular
subtype, the stage of your cancer and whether your cancer has spread
are all equally important in shaping prognosis.
These things also determine the treatments your doctor will recommend.
-
Type of Mesothelioma
There are several types of mesothelioma, each
with its own prognosis. Statistically speaking, peritoneal patients
have a better chance at long-term survival than those with any other
type.
Research shows that approximately 40 percent of
patients with the pleural form of the disease will survive for one year
after diagnosis, while new treatments for peritoneal like heated
chemotherapy have increased survival to more than seven years for some
patients.
10 percent of pleural mesothelioma patients survive > 5 years
The prognosis for pericardial mesothelioma is generally
worse than for pleural and peritoneal. And while testicular mesothelioma
is the rarest type, its prognosis is typically the best.
Learn more about the different types of mesothelioma
-
Stage of Mesothelioma
The size of a tumor and how far it has spread
(metastasized) from its original location affects prognosis. Doctors
typically discuss tumor size and the extent of a cancer's spread in
terms of stages, ranging from stage I to stage IV in order of severity.
Patients with stage I or stage II (early-stage) will typically have a
better prognosis than patients with stage III or stage IV (advanced).
In stage I and II, the cancer hasn’t metastasized
much and remains contained within the lung lining and lung tissue,
allowing for easier removal of tumors through surgery. By stage III, the
cancer is still operable, but has metastasized beyond the lung and its
lining and into the chest wall, nearby lymph nodes or the heart’s
lining. Metastasis at stage IV is so extensive — tumors spread beyond
the chest and into the spine, abdomen or other body parts — that surgery
becomes ineffective.
Learn more about the stages of mesothelioma
-
Cell Type Impacts Survival
The type of cells that make up your tumor, what
doctors call histology, can impact your prognosis. Patients with
epithelial mesothelioma generally have a better life expectancy than
those with either the sarcomatoid or biphasic subtypes.
Learn more about cell types
-
Progression of Symptoms
Patients suffering from serious symptoms, like
severe chest pain or difficulty breathing, may have a worse outlook.
This is because the presence of symptoms often means cancer has already
progressed to a later stage of development.
Learn more about the symptoms of mesothelioma
-
Overall Health
People in otherwise good health may qualify for
treatments that are more intensive. On the other hand, if you have
pre-existing health issues, you may not be able to tolerate aggressive
surgery or chemotherapy. Additionally, non-smokers often have a better mesothelioma prognosis than patients who smoke.
-
Additional factors, such as age, gender and history of asbestos exposure can also affect your prognosis.
Favorable Prognostic Factors |
Poor Prognostic Factors |
Stage I or Stage II cancer |
Stage III or Stage IV cancer |
Tumor located in one area of the body |
Tumor has spread to other parts of the body |
Good overall health |
Pre-existing health conditions or poor overall health |
Epithelial cell type |
Sarcomatoid or biphasic cell type |
Age 55 or below |
Over age 55 |
Non-smoker |
Smoker |
Female |
Male |
Current Prognosis Studies:
As results from ongoing asbestos-related cancer studies surface,
doctors learn more about the diseases. New data leads to more accurate
prognosis estimates. New research on cases reported to the National
Cancer Institute from 2003 to 2009 show that 14.1 percent of women with
pleural mesothelioma survive for five years, compared with only 6
percent of men. Additionally, a 2011 pleural mesothelioma study at
Brigham and Women's Hospital in Massachusetts involving 636 patients
found that patients who underwent an aggressive surgery called extrapleural pneumonectomy (EPP) experienced extended survival.
Another surgery called pleurectomy/decortication
(P/D) has improved survival. A 2012 European study reported longer
survival among epithelioid pleural mesothelioma patients who had a
pleurectomy/decortication (P/D) surgery versus EPP surgery. Patients who
had a P/D lived an average of 30 months while EPP patients lived for 14
months.
A 2015 Italian study found that age, epithelioid cell type and
cancer-free lymph nodes were prognostic factors associated with
long-term survival in pleural mesothelioma patients who had an EPP.
Nearly 23 percent of the study’s 468 participants lived longer than
three years.
Improving and Beating Your Prognosis
While you can't change important prognostic factors like your
age, gender or cancer stage, you can choose to be proactive and take
steps to improve your prognosis.
Find a Mesothelioma Specialist
A specialist is essential in providing you or a loved one with a treatment plan that can improve your life expectancy.
Find a Specialist
Beating the typical prognosis is happening more frequently with
advances in treatment and care for mesothelioma patients. Survivors
credit life span increases to multimodal treatment, improvements in
nutrition and complementary medicines. There are other factors and ways
that can play a part in improving a patient's prognosis.
Early Detection
Those diagnosed early in the cancer’s development have the best
prognosis and longest survival. If doctors can diagnose the disease
before it spreads into lymph nodes and to other parts of the body,
treatment is more successful.
Other Ways
Enrolling in a clinical trial might improve your prognosis. These
studies test up-and-coming therapies that may be more effective than
current treatment options.
Once you've started treatment, you can take a few extra steps to
improve your chances of recovery. If you're a smoker, find a cessation
program. Smoking increases your risk of lung complications if you opt
for surgery, so you should stop immediately. You can also talk to an
oncology dietitian about how to strengthen your body through your diet,
or ask your practitioner about complementary therapies that can help control your symptoms.
Survivors Who Have Surpassed Their Prognosis
Living with mesothelioma is far from easy, but not impossible. The latest treatment regimens,
which often combine surgery with chemotherapy and radiation therapy,
have helped many people survive past the disease's average life
expectancy of one year. In some exceptional cases, mesothelioma
survivors have lived with the cancer for more than a decade.
-
Judy G.
Judy, diagnosed with pleural
mesothelioma in 1990, survived nearly 20 years. She extended her
prognosis with extensive surgeries and radiation therapy. She also drank
mangosteen juice and believed in the power of prayer. Judy shared her
journey with the mesothelioma community in a book, Surviving
Mesothelioma: Making your Own Miracle.
Read Judy's full story in our free book
-
Wayne N.
Wayne, another 20-year
survivor, is a former union electrician who was diagnosed with
peritoneal mesothelioma in 1991. Still fighting, Wayne attributes his
success to antioxidants found in red tart cherries, which he eats
nightly.
Read Wayne's full story
-
Kasie Coleman
Kasie Coleman is a wife and
mother of two who was diagnosed with peritoneal mesothelioma in 2010.
After a series of misdiagnoses, Kasie opted for several cycles of
chemotherapy and two HIPEC (surgery with heated chemotherapy) treatments
that put her cancer into remission in 2012. Since then, she has opened
her own cupcake bakery in Baton Rouge, Louisiana.
In one of several blogs she's
written for The Mesothelioma Center, Kasie stresses the importance of
keeping a positive attitude and viewing yourself as an exception to
mesothelioma's bleak prognosis. Hold tight to the hope that you'll join
the growing community of remarkable mesothelioma survivors.
Read Kasie's full story
Additional Resources
Karen Selby is a registered nurse and a
Patient Advocate at The Mesothelioma Center. She worked in several
subspecialties within nursing before joining Asbestos.com in 2009.